Executive Summary
Dihexa is the Peptide for Cognitive Performance by X Sun·2021·Cited by 12—The endogenous hexapeptide angiotensin IV (Ang IV), an important component of the brain RAS, was found to rescue cognitive impairment and recover memory in
The world of nootropics and cognitive enhancers is constantly evolving, and Dihexa peptide has emerged as a compound of significant interest. While the name "Dihexa" is becoming increasingly recognized, understanding its scientific nomenclature and the entities it relates to is crucial for a comprehensive grasp of its potential. This article delves into the various other names for Dihexa peptide, its underlying scientific classification, and its connection to key biological pathways, providing an in-depth look for those interested in its applications and research.
One of the primary objectives for many searching for Dihexa peptide other name is to uncover its precise chemical identity. Scientifically, Dihexa is recognized by several complex names that reflect its molecular structure. Among these is N-(1-Oxohexyl)-l-tyrosyl-N-(6-amino-6-oxohexyl)- l-isoleucinamide. This designation highlights its composition as an amide, a class of organic compounds often found in biological systems. Furthermore, it is frequently referred to as N-hexanoic-tyrosine-isoleucine-(6) aminohexanoic amide or the slightly varied N-hexanoic-Tyr-Ile-(6) aminohexanoic amide. These names are descriptive of its constituent amino acids and the hexanoic acid modification.
Beyond its detailed chemical names, Dihexa is also known by its research code name, PNB-0408. This identifier is commonly used in scientific literature and clinical studies, offering a concise way to refer to the compound during its developmental stages. For researchers and those tracking its progress, understanding these different designations is vital for accurate information retrieval.
The scientific community also frequently refers to Dihexa by its broader classifications, such as oligopeptide or small peptide. This classification emphasizes its nature as a short chain of amino acids, distinguishing it from larger proteins. Importantly, Dihexa is an angiotensin IV-derived drug and an analog of Angiotensin IV (Ang IV). Angiotensin IV itself is a naturally occurring peptide within the brain's Renin-Angiotensin System (RAS), playing a role in cognitive functions. Dihexa's design as a derivative aims to leverage and potentially enhance these effects.
Its functional classification is also noteworthy. Dihexa is considered a nootropic drug, a term used for substances that may improve cognitive functions such as memory, creativity, or motivation. This is why it's also described as a cognitive enhancer or a peptide for cognitive performance. Its mechanism of action is linked to its ability to activate the hepatocyte growth factor/c-Met (HGF/c-Met) system. This interaction is significant, as the HGF/c-Met pathway is crucial for cell growth, survival, and tissue regeneration, including in neural tissues. The binding affinity of Dihexa to HGF is reported to be very high, with a Kd = 65 pM, indicating a potent interaction.
Research indicates that Dihexa is an orally active and blood-brain barrier-permeable compound. This characteristic is critical for its potential as a therapeutic agent for neurological conditions, as it allows the peptide to reach its target sites within the central nervous system. The ability to cross the blood-brain barrier is a key factor in its development for conditions affecting brain health.
The potential applications of Dihexa are primarily focused on cognitive enhancement and the treatment of neurodegenerative disorders. It is being investigated for its role in promoting synaptogenesis—the formation of new neural connections—which is fundamental for learning and memory. This makes it a subject of interest for conditions like Alzheimer's disease and other forms of dementia, where the loss of neural connections is a hallmark. The compound is also explored for its potential in brain regeneration, leading to descriptions like DIHEXA: Brain Regeneration Peptide.
While the research is promising, it's important to note that Dihexa is still largely in the research and development phase. Some studies have indicated toxicological properties in cell culture experiments and animal studies, underscoring the need for continued investigation into its safety profile and efficacy.
In summary, Dihexa peptide is a multifaceted compound with a range of scientific and descriptive names. Understanding its identity as N-(1-Oxohexyl)-l-tyrosyl-N-(6-amino-6-oxohexyl)- l-isoleucinamide, N-hexanoic-tyrosine-isoleucine-(6) aminohexanoic amide, PNB-0408, an oligopeptide, and an angiotensin IV analog provides a clearer picture of its chemical nature and origins. Its classification as a nootropic drug and its role as an activator of the HGF/c-Met system highlight its significant potential in the field of neuroscience and cognitive health. As research progresses, the full scope of Dihexa's capabilities and applications will continue to be unveiled.
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
